Total submissions: 11
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000881721 | SCV001024912 | likely benign | not provided | 2024-01-28 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV002501388 | SCV002805805 | likely benign | Basal laminar drusen; Factor H deficiency; Hemolytic uremic syndrome, atypical, susceptibility to, 1; Age related macular degeneration 4 | 2021-11-27 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000881721 | SCV004125146 | likely benign | not provided | 2024-01-01 | criteria provided, single submitter | clinical testing | CFH: BP4 |
Genome- |
RCV003446521 | SCV004172473 | likely benign | Hemolytic uremic syndrome, atypical, susceptibility to, 1 | 2023-04-11 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV003446524 | SCV004172474 | likely benign | Age related macular degeneration 4 | 2023-04-11 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV003446523 | SCV004172475 | likely benign | Basal laminar drusen | 2023-04-11 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV003446522 | SCV004172476 | likely benign | Factor H deficiency | 2023-04-11 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV000881721 | SCV005258750 | likely benign | not provided | criteria provided, single submitter | not provided | ||
Clinical Genetics, |
RCV001700486 | SCV001923362 | benign | not specified | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV000881721 | SCV001930565 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000881721 | SCV001968555 | likely benign | not provided | no assertion criteria provided | clinical testing |